Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (opens in new tab)

(nejm.org)

1 pointsmathoff9y ago1 comments

1 comments

"RESULTS At 48 weeks, the least-squares mean percentage reduction in LDL cholesterol levels with evolocumab, as compared with placebo, was 59% [...]"

j / k navigate · click thread line to collapse

(nejm.org)

1 pointsmathoff9y ago1 comments

mathoffOP9y ago

"RESULTS At 48 weeks, the least-squares mean percentage reduction in LDL cholesterol levels with evolocumab, as compared with placebo, was 59% [...]"

j / k navigate · click thread line to collapse